Abstract Background Epertinib (S-222611) is a potent reversible inhibitor of HER2. EGFR and HER4. This trial evaluated the safety. tolerability. https://www.jmannino.com/best-catch-University-of-Miami-The-U-iPhone-14-Plus-Clear-Case-p36265-quick-deal/